Lv1
10 积分 2024-12-20 加入
Xalnesiran With or Without an Immunomodulator in Chronic Hepatitis B
5小时前
待确认
OS-030 Efficacy and safety of xalnesiran with and without an immunomodulator in virologically suppressed participants with chronic hepatitis B: end of study results from the phase 2, randomized, controlled, adaptive, open-label platform study (PIRANGA)
5小时前
已完结
皖公网安备34019202002308
